NEUROLOGIE PRO PRAXI / Neurol. praxi. 2024;25(4):274-281 / www.neurologiepropraxi.cz 280 HLAVNÍ TÉMA Extra‑axiální tumory centrální nervové soustavy z pohledu patologa dují pečlivé morfologické a genetické vyšetření. WHO klasifikace poskytuje rámec pro jejich kategorizaci a grading. Nejčastějšími primárními extra‑axiálními nádory jsou meningiomy, vyházející z arachnotelu. Mezi vzácnější nádory se vztahem k mozkovým plenám lze zařadit solitární fibrózní tumor a melanocytární tumory plen. Mezi nádory kraniálních a paraspinálních nervů dominují schwannomy a neurofibromy. Vzácnějšími patologickými jednotkami jsou spinální hemangioblastomy a CENETy. Znalost jednotlivých extra‑axiálních tumorů je klíčová pro poskytnutí optimální péče pacientům. Vznik tohoto textu byl podpořen projektem BBMRI‑CZ LM2023033; projektem BBMRI‑CZ: Síť biobank – univerzální platforma k výzkumu etiopatogeneze chorob, reg. č.: EF16_013/0001674; programem Cooperatio, vědní oblast DIAG Univerzity Karlovy v Praze a programem MO1012 Ministerstva obrany České republiky. LITERATURA 1. Abedalthagafi M, Bi WL, Aizer, et al. Oncogenic PI3K muta‑ tions are as common as AKT1 and SMO mutations in me‑ ningioma. Neuro Oncol. 2016;18(5):649-655. doi:10.1093/ne‑ uonc/nov316. 2. Agnihotri S, Jalali S, Wilson MR, et al. The genomic land‑ scape of schwannoma. Nat Genet. 2016;48(11):1339-1348. doi:10.1038/ng.3688. 3. Alexiev BA, Chou PM, Jennings LJ. Pathology of Melano‑ tic Schwannoma. Arch Pathol Lab Med. 2018;142(12):1517-1523. doi:10.5858/arpa.2017-0162-RA. 4. Antonescu CR, Owosho AA, Zhang L, et al. Sarcomas With CIC‑rearrangements Are a Distinct Pathologic Entity With Ag‑ gressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases. Am J Surg Pathol. 2017;41(7):941-949. doi:10.1097/ PAS.0000000000000846. 5. Clark VE, Erson‑Omay EZ, Serin A, et al. Genomic analysis of non‑NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science. 2013;339(6123):1077-1080. doi:10.1126/ science.1233009. 6. Clark VE, Harmanci AS, Bai H, et al. Recurrent somatic muta‑ tions in POLR2A define a distinct subset of meningiomas. Nat Genet. 2016;48(10):1253-1259. doi:10.1038/ng.3651. 7. Cleven AH, Sannaa GA, Briaire‑de Bruijn I, et al. Loss of H3K27 tri‑methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an in‑ ferior survival. Mod Pathol. 2016;29(6):582-590. doi:10.1038/ modpathol.2016. 45. 8. Daoud EV, Zhu K, Mickey B, et al. Epigenetic and genomic profiling of chordoid meningioma: implications for clini‑ cal management. Acta Neuropathol Commun. 2022;10(1):56. doi:10.1186/s40478-022-01362-3 9. Eefting D, Schrage YM, Geirnaerdt MJ, et al. Assessment of interobserver variability and histologic parameters to impro‑ ve reliability in classification and grading of central cartilagi‑ nous tumors. Am J Surg Pathol. 2009;33(1):50-57. doi:10.1097/ PAS.0b013e31817eec2b. 10. Folpe AL. „Hey! Whatever happened to hemangiopericy‑ toma and fibrosarcoma?“ An update on selected conceptual advances in soft tissue pathology which have occurred over the past 50 years. Hum Pathol. 2020;95:113-136. doi:10.1016/j. humpath.2019. 10. 001. 11. Griewank KG, Koelsche C, van de Nes JAP, et al. Integrated Genomic Classification of Melanocytic Tumors of the Cent‑ ral Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling. Clin Cancer Res. 2018;24(18):4494-4504. doi:10.1158/1078-0432.CCR-18-0763. 12. Han N, Kim H, Min SK, et al. Meningeal Solitary Fibrous Tu‑ mors with Delayed Extracranial Metastasis. J Pathol Transl Med. 2016;50(2):113-121. doi:10.4132/jptm.2015. 10. 30. 13. Hausler M, Schaade L, Ramaekers VT, et al. Inflammato‑ ry pseudotumors of the central nervous system: report of 3 cases and a literature review. Hum Pathol. 2003;34(3)253-262. doi:10.1053/hupa.2003. 35. 14. Cha YJ, Suh YL. Chordomas: Histopathological Stu‑ dy in View of Anatomical Location. J Korean Med Sci. 2019;34(13):e107. doi:10.3346/jkms.2019. 34. e107. 15. Choudhury A, Magill ST, Eaton CD, et al. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet. 2022;54(5):649-659. doi:10.1038/s41588-022-01061-8. 16. Jankovic D, Vuong K, Splavski B, et al. Supratentorial He‑ mangioblastoma in Adults: A Systematic Review and Com‑ parison of Infratentorial and Spinal Cord Locations. World Neurosurg. 2023;173:48-62. doi:10.1016/j.wneu.2023. 02. 071. 17. Jo VY, Fletcher CD. Epithelioid malignant peripheral nerve sheath tumor: clinicopathologic analysis of 63 ca‑ ses. Am J Surg Pathol. 2015;39(5):673-682. doi:10.1097/ PAS.0000000000000379. 18. Joe WH, Lee CY, Kim CH, et al. Breast Cancer to Menin‑ gioma: A Rare Case of Tumor‑to‑Tumor Metastasis. Brain Tumor Res Treat. 2023;11(1):73-78. doi:10.14791/btrt.2022.0042. 19. Kremenevski N, Schlaffer SM, Coras R, et al. Skull Base Chordomas and Chondrosarcomas. Neuroendocrinology. 2020;110(9-10):836-847. doi:10.1159/000509386. 20. Kusters‑Vandevelde HV, Kusters B, van Engen‑van Gruns‑ ven AC, et al. Primary melanocytic tumors of the central ner‑ vous system: a review with focus on molecular aspects. Brain Pathol. 2015;25(2):209-226. doi:10.1111/bpa.12241. 21. Lee JC, Villanueva‑Meyer JE, Ferris SP, et al. Primary intra‑ cranial sarcomas with DICER1 mutation often contain pro‑ minent eosinophilic cytoplasmic globules and can occur in the setting of neurofibromatosis type 1. Acta Neuropathol. 2019;137(3):521-525. doi:10.1007/s00401-019-01960-x. 22. Li S, Chen Z, Le LQ. New insights into the neurofibroma tumor cells of origin. Neurooncol Adv. 2020;2(Suppl. 1):i13-i22. doi:10.1093/noajnl/vdz044. 23. Lonser RR, Glenn GM, Walther M, et al. von Hippel‑Lindau disease. Lancet. 2003;361(9374): 2059-2067. doi:10.1016/S01406736(03)13643-4. 24. Macagno N, Vogels R, Appay R, et al. Crading of menin‑ geal solitary fibrous tumors/hemangiopericytomas: ana‑ lysis of the prognostic value of the Marseille Grading Sys‑ tem in a cohort of 132 patients. Brain Pathol. 2019;29(1):18-27. doi:10.1111/bpa.12613. 25. Martin‑Broto J, Mondaza‑Hernandez JL, Moura DS, Hin‑ di N. A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons. Cancers (Basel). 2021;13(12). doi:10.3390/cancers13122913. 26. McMenamin ME, Fletcher CD. Expanding the spectrum of malignant change in schwannomas: epithelioid malig‑ nant change, epithelioid malignant peripheral nerve sheath tumor, and epithelioid angiosarcoma: a study of 17 cases. Am J Surg Pathol. 2001;25(1):13-25. doi:10.1097/00000478200101000-00002. 27. Mehrian‑Shai R, Yalon M, Moshe I, et al. Identification of genomic aberrations in hemangioblastoma by droplet digi‑ tal PCR and SNP microarray highlights novel candidate genes and pathways for pathogenesis. BMC Genomics. 2016;17:56. doi:10.1186/s12864-016-2370-6. 28. Miettinen MM, Antonescu CR, Fletcher CDM, et al. Histo‑ pathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a con‑ sensus overview. Hum Pathol. 2017;67:1-10. doi:10.1016/j.hum‑ path.2017. 05. 010. 29. Oakley GJ, Fuhrer K, Seethala RR. Brachyury, SOX-9, and po‑ doplanin, new markers in the skull base chordoma vs chon‑ drosarcoma differential: a tissue microarray‑based compara‑ tive analysis. Mod Pathol. 2008;21(12):1461-1469. doi:10.1038/ modpathol.2008.144. 30. Olbryt M. Molecular background of skin melanoma development and progression: therapeutic implications. Postepy Dermatol Alergol. 2019;36(2):129-138. doi:10.5114/ ada.2019.84590. 31. Ostrom QT, Price M, Neff C, et al. CBTRUS Statistical Re‑ port: Primary Brain and Other Central Nervous System Tu‑ mors Diagnosed in the United States in 2016-2020. Neuro Oncol. 2023;25(Supplement_4):iv1-iv99. doi:10.1093/ne‑ uonc/noad149. 32. Pansuriya TC, van Eijk R, d‚Adamo P, et al. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffuc‑ ci syndrome. Nat Genet. 2011;43(12):1256-1261. doi:10.1038/ ng.1004. 33. Rekhi B, Michal M, Ergen FB, et al. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopatho‑ logical and radiological spectrum of nine cases, including uncommon features of a relatively under‑recognized en‑ tity. Ann Diagn Pathol. 2021;55:151809. doi:10.1016/j.anndia‑ gpath.2021.151809. 34. Robinson DR, Wu YM, Kalyana‑Sundaram S, et al. Iden‑ tification of recurrent NAB2-STAT6 gene fusions in solita‑ ry fibrous tumor by integrative sequencing. Nat Genet. 2013;45(2):180-185. doi:10.1038/ng.2509. 35. Rushing EJ, Bouffard JP, McCall S, et al. Primary extracra‑ nial meningiomas: an analysis of 146 cases. Head Neck Pathol. 2009;3(2):116-130. doi:10.1007/s12105-009-0118-1. 36. Ruttledge MH, Sarrazin J, Rangaratnam S, et al. Evidence for the complete inactivation of the NF2 gene in the majo‑ rity of sporadic meningiomas. Nat Genet. 1994;6(2):180-184. doi:10.1038/ng0294-180. 37. Shively SB, Edwards NA, MacDonald TJ, et al. Developmen‑ tally Arrested Basket/Stellate Cells in Postnatal Human Brain as Potential Tumor Cells of Origin for Cerebellar Hemangiob‑ lastoma in von Hippel‑Lindau Patients. J Neuropathol Exp Neurol. 2022;81(11):885-899. doi:10.1093/jnen/nlac073. 38. Schaefer IM, Fletcher CD, Hornick JL. Loss of H3K27 tri‑ methylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics. Mod Pathol. 2016;29(1):4-13. doi:10.1038/modpathol.2015.134. 39. Schweizer L, Thierfelder F, Thomas C, et al. Molecular cha‑ racterization of CNS paragangliomas identifies cauda equi‑ na paragangliomas as a distinct tumor entity. Acta Neuropathol. 2020;140(6):893-906. doi:10.1007/s00401-020-02218-7. 40. Sievers P, Sill M, Blume C, et al. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1. Acta Neuropathol. 2021;141(2):281-290. doi:10.1007/s00401-020-02247-2. 41. Sloan EA, Chiang J, Villanueva‑Meyer JE, et al. Intracranial mesenchymal tumor with FET‑CREB fusion‑A unifying dia‑ gnosis for the spectrum of intracranial myxoid mesenchy‑ mal tumors and angiomatoid fibrous histiocytoma‑like ne‑ oplasms. Brain Pathol. 2021;31(4):e12918. doi:10.1111/bpa.12918. 42. Soukup J, Kasparova P, Vajda M, Ryska A. Adrenal me‑ tastasis of anaplastic meningioma: report of a rare case. Folia Neuropathol. 2019;57(4):366-372. doi:10.5114/fn.2019.91195. 43. Soukup J, Kohout A, Vosmikova H, et al. Calcifying pseu‑
RkJQdWJsaXNoZXIy NDA4Mjc=